F. A. Guisasola

Consensus on insulin treatment in type 2 diabetes.

F. Gómez-Peralta, F. Jiménez, Diego Fernández García, 2018 .

Position statement of the SEMI, SED, redGDPS, SEC, SEEDO, SEEN, SEMERGEN y SEMFYC

F. Casanueva, E. Galve, F. Peralta, 2015 .

Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) study

G. Nocea, D. Yin, P. Mavros, 2008, Diabetes, obesity & metabolism.

Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes

Javier Mediavilla Bravo, F. Tejedor, J. Núñez-Cortés, 2011 .

Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) Study

G. Krishnarajah, D. Yin, P. Mavros, 2008, Diabetes, obesity & metabolism.

Análisis de costes del tratamiento de la diabetes mellitus tipo 2 con insulina glargina o detemir

F. A. Guisasola, C. Rubio-terrés, D. M. Puente, 2010 .

Análisis de costes del tratamiento de la diabetes mellitus tipo 2 con insulina glargina o detemir Costs analysis of type 2 diabetes mellitus treatment with insulin glargine or detemir

C. Rubio-Terrés, F. A. Guisasola, C. Rubio-terrés, 2016 .